江蘇荃信生物醫藥股份有限公司（02509）于2025年12月30日公告翌日披露报表，披露当日回购股份共267,400股，约占现有已发行股本的0.1183%。每股回购价格介乎每股17.80港元至19.08港元，总金额约499.71万港元。
本次回购完成后，公司已发行股本维持225,719,600股，库藏股数量增至1,352,000股，合计已发行股份总数依然为227,071,600股。该次回购基于2025年6月20日通过的回购授权，公司可根据该授权回购22,207,160股，至今已回购1,352,000股，占授权总数0.6088%。
公司确认已遵守香港联合交易所有限公司《主板上市规则》等相关规定。公告由公司董事会秘書和聯席公司秘書胡衍保签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.